© 1994 Oxford University Press
OTHER |
Coproporphyrinogene oxidase: gene organization and description of a mutation leading to exon 6 skipping
INSERM U409 and Assoctaton Claude Bernard, Facufté de Médecine Xavier Bichat Université Paris 7, 75018 Paris, France
*To whom correspondence should be addressed
Received June 13, 1994; Accepted June 13, 1994
Genomic clones containing a human coproporphyr-inogen oxidase gene, were Isolated. DNA sequencing Indicates that the human CPX gene spans about 14 kb and consists of seven exons and six introns. Sequences were determined for all the exons, exon-Intron junctions and for 800 bp of promoter region. Introns vary in size from 269 bp to 5 kb and they all have consensus sequences at their boundaries. Primer extension and ribonuclease protection experiments revealed multiple transcriptional initiation sites In a region with sequence motifs characteristic of a promoter. The promoter region is GC-rich and contains multiple potential Sp1 elements, CACCC boxes and potential GATA-1 binding sites. The availability of the CPX genomic sequence allowed us to determine the mutation in a patient with a hereditary coproporphyria. A G to A mutation was found at the last position of exon 6. This mutation results in exon skipping.
+These authors contributed equally to this work
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
T. Li and J. S. Woods Cloning, Expression, and Biochemical Properties of CPOX4, a Genetic Variant of Coproporphyrinogen Oxidase that Affects Susceptibilitly to Mercury Toxicity in Humans Toxicol. Sci., June 1, 2009; 109(2): 228 - 236. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Hanaoka, S. Katayama, I. B. Dawid, and A. Kawahara Characterization of the heme synthesis enzyme coproporphyrinogen oxidase (CPO) in zebrafish erythrogenesis Genes Cells, March 1, 2006; 11(3): 293 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schmitt, L. Gouya, E. Malonova, J. Lamoril, J.-M. Camadro, M. Flamme, C. Rose, S. Lyoumi, V. Da Silva, C. Boileau, et al. Mutations in human CPO gene predict clinical expression of either hepatic hereditary coproporphyria or erythropoietic harderoporphyria Hum. Mol. Genet., October 15, 2005; 14(20): 3089 - 3098. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-S. Lee, E. Flachsova, M. Bodnarova, B. Demeler, P. Martasek, and C. S. Raman Structural basis of hereditary coproporphyria PNAS, October 4, 2005; 102(40): 14232 - 14237. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Takeuchi, M. Kondo, M. Daimon, S. Susa, K. Ueoka, O. Uemura, and H. Togari Neonatal-onset hereditary coproporphyria with male pseudohermaphrodism Blood, December 15, 2001; 98(13): 3871 - 3873. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. O. Doss, A. Kuhnel, and U. Gross ALCOHOL AND PORPHYRIN METABOLISM Alcohol Alcohol., March 1, 2000; 35(2): 109 - 125. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. I. Aizencang, D. F. Bishop, D. Forrest, K. H. Astrin, and R. J. Desnick Uroporphyrinogen III Synthase. AN ALTERNATIVE PROMOTER CONTROLS ERYTHROID-SPECIFIC EXPRESSION IN THE MURINE GENE J. Biol. Chem., January 28, 2000; 275(4): 2295 - 2304. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takahashi, S. Taketani, J.-e. Akasaka, A. Kobayashi, N. Hayashi, M. Yamamoto, and T. Nagai Differential Regulation of Coproporphyrinogen Oxidase Gene Between Erythroid and Nonerythroid Cells Blood, November 1, 1998; 92(9): 3436 - 3444. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lamoril, H. Puy, L. Gouya, R. Rosipal, V. Da Silva, B. Grandchamp, T. Foint, B. Bader-Meunier, J.P. Dommergues, J.C. Deybach, et al. Neonatal Hemolytic Anemia Due to Inherited Harderoporphyria: Clinical Characteristics and Molecular Basis Blood, February 15, 1998; 91(4): 1453 - 1457. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Ponka Tissue-specific regulation of iron metabolism and heme synthesis: distinct control mechanisms in erythroid cells Blood, January 1, 1997; 89(1): 1 - 25. [Abstract] [Full Text] |
||||






